News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
146 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (8)
2 (146)
3 (83)
4 (7)
5 (215)
6 (50)
7 (4)
8 (8)
9 (162)
10 (176)
11 (140)
12 (138)
13 (79)
14 (3)
15 (2)
16 (148)
17 (198)
18 (151)
19 (189)
20 (83)
21 (5)
22 (6)
23 (133)
24 (183)
25 (184)
26 (185)
27 (83)
28 (1)
29 (3)
30 (152)
31 (162)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Deals
CEL-SCI Announces the Closing of Its $5 Million Registered Direct Offering and Concurrent Private Placement
CEL-SCI Corporation announced that it has closed its previously announced registered direct offering and concurrent private placement with institutional investors.
July 2, 2018
·
3 min read
Business
American Addiction Centers Awards $10,000 in Academic Scholarships
American Addiction Centers (AAC) announced the winners of its 2018 Behavioral Health Academic Scholarship Program.
July 2, 2018
·
1 min read
Pharm Country
Wills Eye Hospital Announces $5 Million Gift for Vision Research - Ushering in New Era of Scientific Advancements
Hospital’s Vision Research Department is renamed The Vickie and Jack Farber Vision Research Center at Wills Eye
July 2, 2018
·
4 min read
Deals
Young Innovations Announces Acquisition of Johnson-Promident
Young Innovations announced the acquisition of Promident, LLC
July 2, 2018
·
2 min read
Pharm Country
Rheonix Announces Breakthrough Environmental Monitoring Technology with the Listeria PatternAlert™ Assay
Automated method enables rapid identification of recurring Listeria patterns direct from enriched sample in six hours
July 2, 2018
·
3 min read
Deals
Centene Completes Transaction with Fidelis Care
Fidelis Care Becomes Centene’s Health Plan in New York State Expands Centene’s National Leadership in Government Sponsored Healthcare
July 2, 2018
·
10 min read
Business
Evive Launches Internal Incubator To Develop The Next Wave Of Tech Innovations For Solving HR Challenges
Evive Labs to incubate disruptive solutions based on immersive technologies and machine learning.
July 2, 2018
·
3 min read
Policy
Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner for Foods and Veterinary Medicine Steven Ostroff, M.D., on the ongoing risk of salmonella in kratom products
eginning in February of this year, numerous kratom-containing products have been linked to a large outbreak of salmonellosis. The Food and Drug Administration (FDA) has now concluded its months-long investigation after identifying extremely high rates of salmonella contamination in kratom products collected and tested.
July 2, 2018
·
6 min read
Deals
Tricida Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Tricida, Inc. (NASDAQ: TCDA), a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-dosed polymer drug designed to treat metabolic acidosis in patients with...
July 2, 2018
·
2 min read
Deals
Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) on June 29, 2018
Akebia Therapeutics, Inc. granted six newly-hired employees options to purchase an aggregate of 12,050 shares of Akebia’s common stock on June 29, 2018
July 2, 2018
·
1 min read
Previous
10 of 15
Next